
|Articles|May 29, 2012
Insurers Forcing Patients to Pay More for Costly Specialty Drugs
Advertisement
prescription drugs
cancer
r
heumatoid arthritis
Thousands of patients in California and across the nation who take expensive every month for , and other ailments are facing sticker shock at the pharmacy.
Aetna
Until recently, most of these patients typically paid modest co-pays for the advanced drugs. But increasingly, Anthem Blue Cross, and other insurers are shifting more prescriptions to a new category requiring patients to shoulder a larger share of the drug's cost.
Read the full story:
Source: Los Angeles Times
Advertisement
Advertisement
Advertisement
Trending on AJMC
1
Tozorakimab Curbs Multiple COPD Inflammatory Pathways, ERS Data Show
2
Primary Care Capacity Gaps Threaten Respiratory Prevention
3
COPERNICOS Trial: Eosinophil-Guided ICS Reduction Safe in COPD, Vestbo Says
4
FDA Approves Camizestrant for ER+, HER2– mBC With ESR1 Mutations
5




